JPMORGAN CHASE & CO - PROTARA THERAPEUTICS INC ownership

PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 34 filers reported holding PROTARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PROTARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18
-98.2%
11
-96.9%
0.00%
Q2 2022$1,000
-85.7%
352
-68.1%
0.00%
Q4 2021$7,000
-87.5%
1,103
-86.3%
0.00%
Q3 2021$56,000
+2700.0%
8,040
+4442.4%
0.00%
Q2 2021$2,000
-91.7%
177
-88.6%
0.00%
Q1 2021$24,000
-41.5%
1,553
-9.3%
0.00%
Q4 2020$41,000
+57.7%
1,713
+13.1%
0.00%
Q3 2020$26,000
-42.2%
1,515
-1.9%
0.00%
Q2 2020$45,0001,5440.00%
Other shareholders
PROTARA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,558,472$43,059,0008.42%
CVI Holdings, LLC 168,836$2,842,0001.16%
Soleus Capital Management, L.P. 100,000$1,683,0000.89%
Ikarian Capital, LLC 722,443$12,158,0000.88%
COWEN AND COMPANY, LLC 124,171$2,090,0000.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 782,670$13,172,0000.32%
Cormorant Asset Management, LP 450,000$7,574,0000.29%
Rock Springs Capital Management LP 643,622$10,832,0000.28%
Perceptive Advisors 608,544$10,242,0000.15%
Maven Securities LTD 100,000$1,688,0000.14%
View complete list of PROTARA THERAPEUTICS INC shareholders